SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Bishop who wrote (54104)7/11/2000 11:24:25 AM
From: Qone0   of 150070
 
VRDE news.



Veridien Announces Marketing Agreement That Could Dramatically Impact Sales
Sales Force Increases by 28 National Representatives
ST. PETERSBURG, Fla.--(BUSINESS WIRE)--July 11, 2000--Veridien Corporation (OTCBB:VRDE - news), a Health Care products company focusing on infection control and other ``HEALTHY LIFESTYLE'' products, announced today that KT Medical Sales, Inc., a highly acclaimed network of professional sales brokers have agreed to represent the Veridien line of products to the medical and dental community. KT Medical has assembled twenty-eight representatives nationally with a wealth of experience and contacts to launch and expand the Viraguard® products to distributors, hospitals, emergency medical services, and long-term care facilities.

Lou Kimble, Vice President of Sales for KT Medical stated, ``We at KT are extremely selective in terms of which corporations we will represent. The Viraguard® and SunSwipe(TM) products are a high quality, professional line of products that fit well with our target audience. We are confident that our customer base will be extremely receptive to purchasing these products.''

Ken Chester, Managing Director of Operations stated, ``In the last few years KT Medical has represented emerging medical device companies and has sold over $26 million of product through major distributors and multi-national corporations including Owens and Minor, Allegiance Healthcare Corporation, and McKesson General Medical. Veridien's products have proven successful in the market place and KT Medical will provide national institutional exposure for these products. KT Medical brings a national customer base that has potential to dramatically increase Veridien sales.''

ABOUT THE COMPANY

Veridien Corporation is a Health Care Company focusing on infection control and has developed UNIQUE PRODUCTS including PATENTED DISINFECTANTS, ANTISEPTIC HAND GELS, SKIN CLEANSERS, LENS CARE, AND SUN PROTECTION PRODUCTS. These products are inherently non-toxic, and are environmentally friendly. The flagship product Viraguard® Hospital Disinfectant/Cleaner & Instrument Presoak is a patented, EPA registered, surface disinfectant, environmentally friendly and nontoxic by OSHA Standard 29 CFR 1910.1200. Viraguard® Antiseptic Hand Gel is an FDA regulated product utilizing Veridien's patented formulation. Product Line Extensions in a variety of delivery systems are scheduled for introduction during the year 2000. Veridien's product line is currently sold nationally through a variety of well-known distributors representing the Medical, Dental, Food, Retail and Specialty markets. Veridien's products are also distributed under private label through major U.S. Corporations. Veridien is currently expanding sales to nationally and regionally known retail drug market chains and looking to expand sales through E-Commerce.

Look for Veridien at: vrde.com And The SunSwipe Corporation L.L.C. at: sun-swipe.com

Special Note: Forward-looking statements in this press release are made pursuant to the ``safe-harbor'' provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, technological changes and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements.

--------------------------------------------------------------------------------
Contact:

Veridien Corporation, St. Petersburg
Investor Relations:
Cheryl Ballou, 727/572-5500
Veridien@GTE.net

Email this story - View most popular stories emailed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext